Medifast (MED) Capital Expenditures (2010 - 2026)

Medifast's Capital Expenditures history runs 17 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• Quarterly Capital Expenditures fell 27.99% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.2 million (down 27.29% YoY) and the FY2025 annual result came in at $5.6 million, down 24.68% from the prior year.
• Capital Expenditures was $1.1 million for Q1 2026 at Medifast, down from $1.4 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $9.1 million in Q4 2022 and bottomed at $946000.0 in Q4 2023.
• A 5-year average of $2.2 million and a median of $1.7 million in 2023 frame the typical range for Capital Expenditures.
• Annual changes were most pronounced in 2023 — Capital Expenditures plunged 89.56% — and 2024, when it surged 141.54%.
• Medifast's Capital Expenditures stood at $9.1 million in 2022, then plunged by 89.56% to $946000.0 in 2023, then jumped by 141.54% to $2.3 million in 2024, then plunged by 40.88% to $1.4 million in 2025, then retreated by 18.87% to $1.1 million in 2026.
• Business Quant data shows MED's Capital Expenditures at $1.1 million in Q1 2026, $1.4 million in Q4 2025, and $1.4 million in Q3 2025.